Credit: Getty Images. The Clinical Advisor asked May Koslap-Petraco, DNP PPCNP-BC CPNP FAANP, a pediatric nurse practitioner, ...

Two patients present with hyperpigmented patches on their face and neck. Can you correctly identify each case?

Researchers found that an estimated 4.22 million people were living with glaucoma in the United States in 2022. HealthDay News — An estimated 2.56% of US adults ages 40 years and older have glaucoma, ...

Researchers found that the prevalence of abnormal screens for exposed vs unexposed offspring at age 12 months was 32.3% vs 29.4%.

The rate of sexual dysfunction among men with inflammatory bowel disease (IBD) has been reported to be between 44% and 53.9%, in which the most common type of male infertility was reported to be ...

Evidence suggests that patent ductus arteriosus comprises anywhere from 5% to 10% of all congenital heart disease.

Lumryz is an extended-release formulation of sodium oxybate, a central nervous system (CNS) depressant. Its therapeutic effects are believed to be mediated through GABA B actions at noradrenergic and ...

C, is a University of Georgia alumna. She recently graduated from the Augusta University Physician Assistant program and became board certified.

Prescriptions for GLP-1 RAs less common among White teens vs Black, Hispanic teens. HealthDay News — Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 ...

Ultraprocessed food (UPF) intake accounts for nearly half of toddlers’ energy and increases in mid-childhood, according to a study published online in the Eur ...

Itovebi is supplied as a tablet in 2 dosage strengths: 3 mg and 9 mg. Patients should be selected for treatment based on the presence of 1 or more PIK3CA mutations in plasma specimens. The FDA has ...

The Food and Drug Administration (FDA) has approved Imuldosa ™ (ustekinumab-srlf), a biosimilar to Stelara ® (ustekinumab), for the treatment of various chronic inflammatory diseases. Imuldosa, ...